TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Ariad Pharmaceuticals Inc (NASDAQ: ARIA) Investor Securities Class Action Lawsuit 10/10/2013

  • If you purchased shares of Ariad Pharmaceuticals Inc (NASDAQ: ARIA), you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

May 10, 2018 - The court approved the settlement and entered the orders approving the plan of allocation, the motion for attorneys’ fees and expenses, and dismissing the action with prejudice. January 19, 2018 - The court preliminarily approved the settlement. November 30, 2017 - Parties filed a stipulation of settlement. November 28, 2016 - The Court of Appeals for the First Circ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: